Active — Not RecruitingNot Applicable

Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy

China464 participantsStarted 2025-06-23

Plain-language summary

To predict prostate cancer by ultrasound radiomics in ultrasound fusion prostate targeted biopsy.

Age range55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. malignant tumors other than prostate adenocarcinoma indicated by pathology.
✕. Combined with other malignant tumors (such as rectal cancer, bladder cancer, testicular cancer, etc.) that may affect the imaging findings of transrectal ultrasound or mpMRI.
✕. Other conditions that would preclude needle biopsy: cachexia, decompensation of organ function, hemorrhagic diseases, local infection, etc

Positive rate of ultrasound radiomics fusion targeted biopsy

Timeframe: Up to seventh day when the pathological results were obtained after the targeted biopsy

Positive rate of systematic biopsy

Timeframe: Up to seventh day when the pathological results were obtained after the targeted biopsy

Positive rate of mpMRI cognitive fusion targeted biopsy

Timeframe: Up to seventh day when the pathological results were obtained after the targeted biopsy

Ultrasound radiomics parameters

Timeframe: The 30min following the transrectal ultrasonography

NCT IDNCT05761912

SponsorShanghai Minhang Central Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-02-15